REQUEST A DEMO
Total
USD $0.00
Search more companies

GL Pharm Tech Corp. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: GL Pharm Tech Corp. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

GL Pharm Tech Corp. is engaged in developing, manufacturing and distribution of pharmaceutical products. The company offers incrementally modified drugs for Gastritis, Antidepressant, Anorectic, in addition to generic drugs used to cure cardiovascular diseases, urology, pain killers, anti-infection, gastric diseases, diabetes, CNS disease, respiratory disease, transplantation, among others. GL Pharm Tech Corp. also owns and distributes G-SOREN® Tab, an Artemisia-origined oral herbal product for the prevention and treatment of gastritis. The company is based in Seongnam, Gyeonggi-do Province, South Korea.

Headquarters
5Cha-714, Jungang Induspia, 137, Sagimakgol-Ro, Jungwon-Gu, Seongnam-Si, Gyeonggi-Do
Seongnam; Gyeonggi;

Contact Details: Purchase the GL Pharm Tech Corp. report to view the information.

Website: http://www.glpt.co.kr

Basic Information
Total Employees:
Purchase the GL Pharm Tech Corp. report to view the information.
Outstanding Shares:
Purchase the GL Pharm Tech Corp. report to view the information.
Registered Capital:
Purchase the GL Pharm Tech Corp. report to view the information.
Financial Auditors:
Purchase the GL Pharm Tech Corp. report to view the information.
Incorporation Date:
July 29, 2014
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
9.4%
Purchase this report to view the information.
5.9%
Purchase this report to view the information.
5.2%
Subsidiaries
지엘파마(주)
Company Performance
Financial values in the chart are available after GL Pharm Tech Corp. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
55.62%
Total operating revenue
49.13%
Operating profit (EBIT)
-26.56%
Net Profit (Loss) for the Period
-374.39%
Total assets
-2.41%
Total equity
-23.67%
Operating Profit Margin (ROS)
2.44%
Net Profit Margin
-9.68%
Return on Equity (ROE)
-25.61%
Debt to Equity Ratio
58.35%
Quick Ratio
-0.01%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?